Shopping Cart (0)
My Account

 Shopping Cart
Conferences | Training Courses | Market Reports | Managed Events | Past Conferences | Update Me
SELECTBIO Conferences Lab-on-a-Chip and Microfluidics World Congress 2022
Conferences  \  Lab-on-a-Chip and Microfluidics World Congress 2022  \  Agenda  \  Valérie Taly
RegisterLogin

Valérie Taly's Biography


Valérie Taly, CNRS Research Director, Professor and Group leader Translational Research and Microfluidics, Université Paris Cité

V. Taly is a CNRS research director and group leader of the Translational Research And Microfluidics team within the clinical oncology research unit MEPPOT (personalized medicine pharmacogenomics and therapeutic optimization) in the Cordeliers Research Center (university Paris Cité). Her team performs interdisciplinary researches aiming at developing and validating microfluidic tools for cancer research in close collaboration with clinicians and researchers in oncology and toxicology. Since 2008, she developed droplet-based digital procedures for Cancer diagnosis. Recently, her research has been dedicated to the clinical validation of droplet-based microfluidics for the non-invasive detection of Cancer biomarkers, the highlighting of new Cancer Biomarkers and the development of original tools and procedures for their detection with applications in personalized medicine, cancer recurrence detection and cancer diagnostics. She is co-founder of EMULSEO (2018) and METHYS DX (2021) start up companies.

Valérie Taly Image

Droplet-based Microfluidics Original Droplet-based Digital PCR Assays to Detect Circulating Biomarkers

Monday, 12 December 2022 at 17:00

Add to Calendar ▼2022-12-12 17:00:002022-12-12 18:00:00Europe/LondonDroplet-based Microfluidics Original Droplet-based Digital PCR Assays to Detect Circulating BiomarkersLab-on-a-Chip and Microfluidics World Congress 2022 in Long Beach, CaliforniaLong Beach, CaliforniaSELECTBIOenquiries@selectbiosciences.com

Droplet-based microfluidics has led to the development of highly powerful systems that represent a new paradigm in High-Throughput Screening where individual assays are compartmentalized within microdroplet microreactors. The integration of such systems for series of complex individual operations on droplets has offered a solution to the necessary miniaturization and automation of individual biological assays. By combining a decrease of assay volume and an increase of throughput, this technology goes beyond the capacities of conventional screening systems. The presentation will aim at demonstrating through selected example, the great potential of this technology for biotechnology and cancer research. In particular, we will show how by combining microfluidic systems and clinical advances in molecular diagnostic we have developed an original method to perform millions of single molecule PCR in parallel to detect and quantify a minority of target sequences in complex mixture of nucleic acids with a sensitivity unreachable by conventional procedures. This presentation will both cover early developments of droplet-based digital PCR and more recent one dedicated to the highly sensitive multiplex detection of micro-RNA.

Add to Calendar ▼2022-12-12 00:00:002022-12-14 00:00:00Europe/LondonLab-on-a-Chip and Microfluidics World Congress 2022Lab-on-a-Chip and Microfluidics World Congress 2022 in Long Beach, CaliforniaLong Beach, CaliforniaSELECTBIOenquiries@selectbiosciences.com


Corporate Sponsors
Related Conferences
Lab-on-a-Chip and Microfluidics Europe 2024
Location: Rotterdam, The Netherlands
Date: 24/06/2024 - 25/06/2024


Point-of-Care, Biosensors and Rapid Dx Europe 2024
Location: Rotterdam, The Netherlands
Date: 24/06/2024 - 25/06/2024


Innovations in Microfluidics 2024: Rapid Prototyping, 3D-Printing
Location: Ann Arbor, Michigan
Date: 06/05/2024 - 07/05/2024